$OBMP put it on your radar! OncBioMune Pharmaceuticals Inc (OTCMKTS:OBMP) is a small biotech player we have covered a few times recently, noting that the stock looked increasingly interesting given its R&D assets as either a very cheap buyout target or a deep value lotto ticket in the space for speculative funds. The week is turning out to be a vindication of that outlook as the stock is starting to power higher on the company’s announcement on Wednesday that the key regulatory authority in this matter has granted full authorization to move ahead with the protocol proposed for the Phase 2/3 clinical trial of ProscaVax.

OncBioMune Pharmaceuticals Inc (OTCMKTS:OBMP) Potential Breakthrough Study Could Send Stock Prices Surging
https://www.journaltranscript.com/2017/01/onc...s-surging/